Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
Eur Heart J
    November 2024
  1. CHO S, Eom S, Kim D, Kim TH, et al
    Artificial intelligence-derived electrocardiographic aging and risk of atrial fibrillation: a multi-national study.
    Eur Heart J. 2024 Nov 29:ehae790. doi: 10.1093.
    >> Share

  2. KONERU JN, Ellenbogen KA
    Ablation of persistent atrial fibrillation: lessons learnt from the CAPLA trial.
    Eur Heart J. 2024 Nov 27:ehae832. doi: 10.1093.
    >> Share

  3. MEYER M
    Accelerated pacing as a treatment for heart failure with preserved ejection fraction and atrial fibrillation?
    Eur Heart J. 2024 Nov 26:ehae766. doi: 10.1093.
    >> Share

  4. ORTEGA-MARTORELL S, Olier I, Lip GYH
    A European network to develop virtual twin technology for personalized stroke management in atrial fibrillation: the TARGET consortium.
    Eur Heart J. 2024 Nov 20:ehae673. doi: 10.1093.
    >> Share

  5. LINZ D, Chaldoupi SM
    Stroke risk in device-detected atrial fibrillation is modulated by the continuum of vascular disease burden.
    Eur Heart J. 2024 Nov 19:ehae797. doi: 10.1093.
    >> Share

  6. VERKAIK BJ, Walker RG, Taylor TG, Ekkel MM, et al
    Defibrillation and refractory ventricular fibrillation.
    Eur Heart J. 2024 Nov 18:ehae767. doi: 10.1093.
    >> Share

  7. NEEFS J, Krul SPJ, de Groot JR
    A CHA2DS2-VASc score of 1 is not the same for every patient with atrial fibrillation.
    Eur Heart J. 2024 Nov 11:ehae511. doi: 10.1093.
    >> Share

  8. BORIANI G, Mei DA, Imberti JF
    Personalized clinical management of patients with atrial fibrillation: is a biomarker-based strategy for prediction of sinus rhythm persistence ready for prime time?
    Eur Heart J. 2024 Nov 9:ehae720. doi: 10.1093.
    >> Share

  9. KANY S, Ellinor PT, Khurshid S
    Another piece in the puzzle of atrial fibrillation risk: clinical, genetic, and electrocardiogram-based artificial intelligence.
    Eur Heart J. 2024 Nov 4:ehae691. doi: 10.1093.
    >> Share

    October 2024
  10. LIUZZO G, Patrono C
    Weekly Journal Scan: the rise and OCEANIC fall of asundexian in atrial fibrillation.
    Eur Heart J. 2024 Oct 25:ehae728. doi: 10.1093.
    >> Share

  11. TARANTINO A, Ciconte G, Melgari D, Frosio A, et al
    NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications.
    Eur Heart J. 2024;45:4336-4348.
    >> Share

  12. KARAKASIS P, Pamporis K, Siontis KC, Theofilis P, et al
    Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a meta-analysis.
    Eur Heart J. 2024 Oct 21:ehae694. doi: 10.1093.
    >> Share

  13. CREA F
    Innovative approaches to the management of recurrent atrial fibrillation, aortic dilation, and Brugada syndrome.
    Eur Heart J. 2024;45:4245-4248.
    >> Share

  14. CHARTON J, Bouteiller X, Gandjbakhch E, Waintraub X, et al
    Overdrive pacing for ventricular fibrillation storm after myocardial infarction.
    Eur Heart J. 2024 Oct 18:ehae698. doi: 10.1093.
    >> Share

  15. ORAII A, Healey JS, McIntyre WF
    Mineralocorticoid receptor antagonists for atrial fibrillation prevention: effective solution or empty promise?
    Eur Heart J. 2024 Oct 17:ehae687. doi: 10.1093.
    >> Share

  16. SAMPAIO RODRIGUES T, Sanders P, Lim HS
    Utility of mineralocorticoid receptor antagonists in reducing burden of atrial fibrillation.
    Eur Heart J. 2024 Oct 17:ehae686. doi: 10.1093.
    >> Share


  17. Correction to: An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis.
    Eur Heart J. 2024 Oct 15:ehae394. doi: 10.1093.
    >> Share

  18. JOZA J, Burri H, Andrade JG, Linz D, et al
    Atrioventricular node ablation for atrial fibrillation in the era of conduction system pacing.
    Eur Heart J. 2024 Oct 14:ehae656. doi: 10.1093.
    >> Share

  19. GALIUTO L, Patrono C
    Weekly Journal Scan: Risk factors for recurrent ischaemic stroke in patients with atrial fibrillation on oral anticoagulation.
    Eur Heart J. 2024 Oct 3:ehae630. doi: 10.1093.
    >> Share


  20. Correction to: Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.
    Eur Heart J. 2024 Oct 1:ehae693. doi: 10.1093.
    >> Share

    September 2024
  21. CREA F
    New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies.
    Eur Heart J. 2024;45:3299-3302.
    >> Share

  22. NATALE A, Mohanty S, Sanders P, Anter E, et al
    Catheter ablation for atrial fibrillation: indications and future perspective.
    Eur Heart J. 2024 Sep 26:ehae618. doi: 10.1093.
    >> Share

  23. ECHIVARD M, Sellal JM, Ziliox C, Marijon E, et al
    Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.
    Eur Heart J. 2024 Sep 20:ehae575. doi: 10.1093.
    >> Share

  24. GAWALKO M, Middeldorp ME, Saljic A, Penders J, et al
    Diet and risk of atrial fibrillation: a systematic review.
    Eur Heart J. 2024 Sep 17:ehae551. doi: 10.1093.
    >> Share

  25. SCHNABEL RB, Benezet-Mazuecos J, Becher N, McIntyre WF, et al
    Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.
    Eur Heart J. 2024 Sep 2:ehae596. doi: 10.1093.
    >> Share

  26. HAVERS-BORGERSEN E, Hartwell D, Ekelund C, Butt JH, et al
    Endometriosis and Long-Term Cardiovascular Risk: A Nationwide Danish study.
    Eur Heart J. 2024 Sep 2:ehae563. doi: 10.1093.
    >> Share

  27. LIP GYH, Teppo K, Nielsen PB
    CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications.
    Eur Heart J. 2024 Sep 1:ehae540. doi: 10.1093.
    >> Share

  28. CHAMPSI A, Mobley AR, Subramanian A, Nirantharakumar K, et al
    Gender and contemporary risk of adverse events in atrial fibrillation.
    Eur Heart J. 2024 Sep 1:ehae539. doi: 10.1093.
    >> Share

  29. JABBOUR G, Nolin-Lapalme A, Tastet O, Corbin D, et al
    Prediction of incident atrial fibrillation using deep learning, clinical models and polygenic scores.
    Eur Heart J. 2024 Sep 1:ehae595. doi: 10.1093.
    >> Share

    August 2024
  30. WILLIAM J, Chieng D, Curtin AG, Sugumar H, et al
    Radiofrequency catheter ablation of persistent atrial fibrillation by pulmonary vein isolation with or without left atrial posterior wall isolation: long-term outcomes of the CAPLA trial.
    Eur Heart J. 2024 Aug 31:ehae580. doi: 10.1093.
    >> Share

  31. FABRITZ L, Al-Taie C, Borof K, Breithardt G, et al
    Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study.
    Eur Heart J. 2024 Aug 31:ehae611. doi: 10.1093.
    >> Share

  32. VAN GELDER IC, Rienstra M, Bunting KV, Casado-Arroyo R, et al
    2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2024 Aug 30:ehae176. doi: 10.1093.
    >> Share

  33. HUANG H, Liu Y, Shuai W, Jiang C, et al
    Atrial tachyarrhythmia prevention by Shensong Yangxin after catheter ablation for persistent atrial fibrillation: the SS-AFRF trial.
    Eur Heart J. 2024 Aug 23:ehae532. doi: 10.1093.
    >> Share

  34. BOVEDA S, Sarkozy A, Duncker D, Merino JL, et al
    European Heart Rhythm Association congress: a constantly reinvented meeting.
    Eur Heart J. 2024;45:2905-2907.
    >> Share

  35. CARRICK RT, Gasperetti A, Protonotarios A, Murray B, et al
    A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers.
    Eur Heart J. 2024;45:2968-2979.
    >> Share

  36. CREA F
    Expanding knowledge in atrial fibrillation, blood pressure treatment, and management of coronary and peripheral artery disease.
    Eur Heart J. 2024;45:2795-2799.
    >> Share

  37. CONTE G, Bergonti M
    Implantable loop recorders in Brugada syndrome: symptoms and arrhythmia characterization.
    Eur Heart J. 2024;45:2895.
    >> Share

  38. DENDRAMIS G
    Implantable loop recorders in patients with Brugada syndrome: the importance of a correct patient stratification.
    Eur Heart J. 2024;45:2894.
    >> Share

  39. BAINS S, Giammarino L, Nimani S, Alerni N, et al
    KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome.
    Eur Heart J. 2024 Aug 8:ehae476. doi: 10.1093.
    >> Share

  40. CREA F
    Spotlight on hot topics: subclinical atrial fibrillation, risk stratification of channelopathies, and cardioprotection.
    Eur Heart J. 2024;45:2579-2583.
    >> Share

  41. TSUJI T, Hasegawa K, Tada H
    Left atrial diverticulum as a rare but possible origin of a sustained atrial tachycardia: a case report.
    Eur Heart J. 2024;45:2679.
    >> Share

    July 2024
  42. KANY S, Jurgens SJ, Ramo JT, Christophersen IE, et al
    Genetic testing in early-onset atrial fibrillation.
    Eur Heart J. 2024 Jul 19:ehae298. doi: 10.1093.
    >> Share

  43. LANDMESSER U, Skurk C, Tzikas A, Falk V, et al
    Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives.
    Eur Heart J. 2024 Jul 19:ehae398. doi: 10.1093.
    >> Share

  44. ANDREOTTI F, De Caterina R
    Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed.
    Eur Heart J. 2024 Jul 16:ehae402. doi: 10.1093.
    >> Share

  45. KAJIHARA Y
    Edoxaban-induced oesophagitis.
    Eur Heart J. 2024;45:2460.
    >> Share

  46. CHOI YJ, Lim J, Bea S, Lee J, et al
    Thromboembolism after coronavirus disease 2019 vaccination in atrial fibrillation/flutter: a self-controlled case series study.
    Eur Heart J. 2024 Jul 12:ehae335. doi: 10.1093.
    >> Share

  47. CONNORS JM
    Thrombotic risks associated with COVID-19 vaccination in atrial fibrillation or atrial flutter: no reason for alarm.
    Eur Heart J. 2024 Jul 12:ehae336. doi: 10.1093.
    >> Share

  48. WILDE AAM, van der Werf C
    Risk scores in congenital long QT syndrome: friend or foe?
    Eur Heart J. 2024 Jul 10:ehae408. doi: 10.1093.
    >> Share

  49. CREA F
    A new classification of iron-deficient heart failure, sex-related differences in the management of atrial fibrillation and mitral regurgitation, and an update on the genetics of Brugada syndrome.
    Eur Heart J. 2024;45:2267-2270.
    >> Share

  50. BEHR ER
    Brugada syndrome: can polygenic risk scores help the clinician?
    Eur Heart J. 2024;45:2333-2335.
    >> Share

  51. SCACCIAVILLANI R
    Percutaneous stellate ganglion block for electrical storm treatment: the new rising STAR?
    Eur Heart J. 2024;45:2263.
    >> Share

  52. SAVASTANO S, Baldi E, Rordorf R
    Percutaneous stellate ganglion block and catheter ablation: not enemies but allies in fighting electrical storm.
    Eur Heart J. 2024;45:2264.
    >> Share

  53. ISHIKAWA T, Masuda T, Hachiya T, Dina C, et al
    Brugada syndrome in Japan and Europe: a genome-wide association study reveals shared genetic architecture and new risk loci.
    Eur Heart J. 2024;45:2320-2332.
    >> Share

  54. AIRAKSINEN KEJ, De Sensi F
    Ten years of direct oral anticoagulants: lessons learned and challenges ahead.
    Eur Heart J. 2024;45:2178-2180.
    >> Share

  55. MURARU D, Badano LP
    Impact of new-onset atrial fibrillation on the incidence of tricuspid regurgitation: a call to attention.
    Eur Heart J. 2024 Jul 8:ehae382. doi: 10.1093.
    >> Share

  56. LV L
    What influences the bleeding risk of long-term anticoagulation after catheter ablation in patients with atrial fibrillation at high risk of thromboembolism?
    Eur Heart J. 2024 Jul 2:ehae388. doi: 10.1093.
    >> Share

  57. KANAOKA K, Iwanaga Y
    Oral anticoagulant use after catheter ablation for atrial fibrillation based on thrombo-embolic risk: future studies will be needed for bleeding high-risk group.
    Eur Heart J. 2024 Jul 2:ehae389. doi: 10.1093.
    >> Share

  58. BECHER N, Metzner A, Toennis T, Kirchhof P, et al
    Atrial fibrillation burden: a new outcome predictor and therapeutic target.
    Eur Heart J. 2024 Jul 2:ehae373. doi: 10.1093.
    >> Share

  59. NASER JA, Castrichini M, Ibrahim HH, Scott CG, et al
    Secondary tricuspid regurgitation: incidence, types, and outcomes in atrial fibrillation vs. sinus rhythm.
    Eur Heart J. 2024 Jul 2:ehae346. doi: 10.1093.
    >> Share

    June 2024
  60. CREA F
    A focus on three hot topics: atrial fibrillation, obesity, and climate change.
    Eur Heart J. 2024;45:2105-2108.
    >> Share

  61. SANDERS P, Svennberg E, Diederichsen SZ, Crijns HJGM, et al
    Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation.
    Eur Heart J. 2024 Jun 27:ehae365. doi: 10.1093.
    >> Share

  62. SAMUEL M, Rienstra M, Van Gelder IC
    Ablation of persistent atrial fibrillation: never say never again.
    Eur Heart J. 2024 Jun 18:ehae374. doi: 10.1093.
    >> Share

  63. KHAIRY P
    A non-invasive gateway to identifying potential substrates for macro-reentrant ventricular tachycardia in tetralogy of Fallot.
    Eur Heart J. 2024;45:2095-2097.
    >> Share

  64. KIMURA Y, Wallet J, Bouyer B, Jongbloed MRM, et al
    Three-dimensional cardiac magnetic resonance allows the identification of slow-conducting anatomical isthmuses in tetralogy of Fallot.
    Eur Heart J. 2024;45:2079-2094.
    >> Share

  65. STEINBERG BA
    Atrial fibrillation and long-term cardiovascular outcomes: bringing the whole picture into focus.
    Eur Heart J. 2024 Jun 7:ehae347. doi: 10.1093.
    >> Share

  66. FARMAKIS D, Filippatos G
    Cancer begets atrial fibrillation ... and vice versa?
    Eur Heart J. 2024 Jun 7:ehae301. doi: 10.1093.
    >> Share

  67. JOHNSON LS, Jiang Y, Luu J, Van Gelder IC, et al
    Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.
    Eur Heart J. 2024 Jun 4:ehae319. doi: 10.1093.
    >> Share

    May 2024
  68. WANG J, Chen X, Zhao S
    Detect and define ventricular arrhythmia substrates in hypertrophic cardiomyopathy.
    Eur Heart J. 2024 May 31:ehae312. doi: 10.1093.
    >> Share

  69. VAN DE KAR MRD, van Brakel TJ, Van't Veer M, van Steenbergen GJ, et al
    Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
    Eur Heart J. 2024 May 29:ehae267. doi: 10.1093.
    >> Share

  70. NAGAE H, Kayawake H, Taniguchi T
    Chest tube-related complete atrioventricular block.
    Eur Heart J. 2024 May 28:ehae315. doi: 10.1093.
    >> Share

  71. BRIEGER D, Freedman B
    Taking the sex out of atrial fibrillation.
    Eur Heart J. 2024 May 24:ehae256. doi: 10.1093.
    >> Share

  72. CHAUHAN A, Banerjee A
    Atrial fibrillation and flutter: reiterating the need to 'Go hard, Go early'.
    Eur Heart J. 2024 May 23:ehae029. doi: 10.1093.
    >> Share

  73. CRIJNS HJGM, Lambiase PD, Sanders P
    The year in cardiovascular medicine 2023: the top 10 papers in arrhythmias.
    Eur Heart J. 2024;45:1730-1732.
    >> Share

  74. CROWLEY R, Chieng D, Sugumar H, Ling LH, et al
    Catheter ablation for persistent atrial fibrillation: patterns of recurrence and impact on quality of life and health care utilisation.
    Eur Heart J. 2024 May 17:ehae291. doi: 10.1093.
    >> Share

  75. DUSI V, Dagradi F, Spazzolini C, Crotti L, et al
    Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation.
    Eur Heart J. 2024 May 16:ehae289. doi: 10.1093.
    >> Share

  76. SABBAG A, Aabel EW, Castrini AI, Siontis KC, et al
    Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum.
    Eur Heart J. 2024 May 14:ehae224. doi: 10.1093.
    >> Share

  77. ZEPPENFELD K, de Riva M
    Arrhythmic risk in young women with mitral valve prolapse: keep your eyes open but don't jump at every shadow.
    Eur Heart J. 2024 May 14:ehae246. doi: 10.1093.
    >> Share

  78. VANDERSICKEL N, Hendrickx S, Van den Abeele R, Verstraeten B, et al
    Impact of topology on the number of loops during macro-re-entrant atrial tachycardia.
    Eur Heart J. 2024;45:1586-1588.
    >> Share

  79. TAN Y, Tao Y, Wang Z
    Isolated right-sided pericardial effusion following hybrid ablation for long-standing atrial fibrillation.
    Eur Heart J. 2024 May 4:ehae210. doi: 10.1093.
    >> Share

    April 2024
  80. NGO LTH, Peng Y, Denman R, Yang I, et al
    Long-term outcomes after hospitalization for atrial fibrillation or flutter.
    Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093.
    >> Share

  81. LI YP, Chen JY
    Rapid onset of takotsubo cardiomyopathy induced by left bundle branch area pacing.
    Eur Heart J. 2024;45:1487.
    >> Share


  82. Correction to: XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
    Eur Heart J. 2024 Apr 17:ehae227. doi: 10.1093.
    >> Share

  83. CHEN Q, van Rein N, van der Hulle T, Heemelaar JC, et al
    Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study.
    Eur Heart J. 2024 Apr 15:ehae222. doi: 10.1093.
    >> Share

  84. TEPPO K, Airaksinen KEJ, Jaakkola J, Halminen O, et al
    Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications.
    Eur Heart J. 2024 Apr 12:ehae198. doi: 10.1093.
    >> Share

  85. PALUDAN-MULLER C, Vad OB, Stampe NK, Diederichsen SZ, et al
    Atrial fibrillation: age at diagnosis, incident cardiovascular events, and mortality.
    Eur Heart J. 2024 Apr 9:ehae216. doi: 10.1093.
    >> Share

  86. LIP GYH, Nikorowitsch J, Sehner S, Becher N, et al
    Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.
    Eur Heart J. 2024 Apr 9:ehae225. doi: 10.1093.
    >> Share

  87. CREA F
    The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
    Eur Heart J. 2024;45:1183-1187.
    >> Share

  88. GAITA F, Cerrato N, Giustetto C
    Can an implantable loop recorder improve risk stratification and appropriate management in Brugada syndrome?
    Eur Heart J. 2024;45:1266-1268.
    >> Share

  89. BERGONTI M, Sacher F, Arbelo E, Crotti L, et al
    Implantable loop recorders in patients with Brugada syndrome: the BruLoop study.
    Eur Heart J. 2024;45:1255-1265.
    >> Share

  90. EL-CHAMI MF, Garweg C, Clementy N, Al-Samadi F, et al
    Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry.
    Eur Heart J. 2024;45:1241-1251.
    >> Share

  91. LIUZZO G, Pedicino D
    Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillation.
    Eur Heart J. 2024 Apr 1:ehae138. doi: 10.1093.
    >> Share

    March 2024
  92. CREA F
    Challenges in arrhythmias: anticoagulation in asymptomatic atrial fibrillation, stellate ganglion block in electrical storm, and ECG for prediction of sudden death.
    Eur Heart J. 2024;45:739-743.
    >> Share

  93. ZURIAGA MA, Pascual-Figal D, Fuster JJ
    Clonal haematopoiesis and cardiac arrythmias: rhythm-altering mutations.
    Eur Heart J. 2024;45:806-808.
    >> Share

  94. SAVASTANO S, Baldi E, Compagnoni S, Rordorf R, et al
    Electrical storm treatment by percutaneous stellate ganglion block: the STAR study.
    Eur Heart J. 2024;45:823-833.
    >> Share

  95. FIALHO GL
    Epilepsy and the heart: can 'brain arrhythmia' lead to cardiac arrhythmias? Back to the basics.
    Eur Heart J. 2024;45:853-854.
    >> Share

  96. PHAM HN, Holmstrom L, Chugh H, Uy-Evanado A, et al
    Dynamic electrocardiogram changes are a novel risk marker for sudden cardiac death.
    Eur Heart J. 2024;45:809-819.
    >> Share

  97. SCHUERMANS A, Vlasschaert C, Nauffal V, Cho SMJ, et al
    Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias.
    Eur Heart J. 2024;45:791-805.
    >> Share

  98. SUN Y, Zhou Y, Yu B, Zhang K, et al
    Frailty, genetic predisposition, and incident atrial fibrillation.
    Eur Heart J. 2024 Mar 5:ehae130. doi: 10.1093.
    >> Share

  99. SUDO K, Nakamura K, Sato A
    Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
    Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
    >> Share

  100. MURARU D, Badano LP, Hahn RT, Lang RM, et al
    Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.
    Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093.
    >> Share

    February 2024
  101. SVENNBERG E, Diederichsen SZ
    Anticoagulation in device-detected atrial fibrillation: a long journey to find the sweet spot.
    Eur Heart J. 2024 Feb 21:ehae044. doi: 10.1093.
    >> Share

  102. CREA F
    Anticoagulation in atrial fibrillation and implantable cardioverter defibrillator implantation in arrhythmogenic right ventricular cardiomyopathy: need for improving patient selection.
    Eur Heart J. 2024;45:491-494.
    >> Share

  103. MALIK V, Shivkumar K
    Stellate ganglion blockade for the management of ventricular arrhythmia storm.
    Eur Heart J. 2024 Feb 15:ehae083. doi: 10.1093.
    >> Share

  104. HOLT A, Nouhravesh N, Strange JE, Kinnberg Nielsen S, et al
    Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study.
    Eur Heart J. 2024;45:475-484.
    >> Share

  105. ZURKAN D, Pitt B, Edelmann F
    Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect?
    Eur Heart J. 2024 Feb 6:ehae040. doi: 10.1093.
    >> Share

  106. LIUZZO G, Patrono C
    Edoxaban for atrial high-rate episodes: more harm than good?
    Eur Heart J. 2024;45:330-331.
    >> Share

    January 2024
  107. ELLIOTT PM
    Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2024 Jan 30:ehae022. doi: 10.1093.
    >> Share

  108. YOUNES H, Rao S, Marrouche N
    Deciphering connections: how is cryoablation interlinking with disease progression in atrial fibrillation ablation?
    Eur Heart J. 2024 Jan 24:ehad872. doi: 10.1093.
    >> Share

  109. BRIENESSE S, Passman R, Freedman B
    Interruption of oral anticoagulants after atrial fibrillation catheter ablation: the importance of risk stratification.
    Eur Heart J. 2024 Jan 23:ehad874. doi: 10.1093.
    >> Share

  110. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
    Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
    Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
    >> Share

  111. VERGALLO R, Galiuto L
    Targeting inflammation with colchicine does not prevent atrial fibrillation after major non-cardiac thoracic surgery.
    Eur Heart J. 2024 Jan 18:ehae006. doi: 10.1093.
    >> Share

  112. AHN HJ, An HY, Ryu G, Lim J, et al
    Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.
    Eur Heart J. 2024 Jan 17:ehad869. doi: 10.1093.
    >> Share

  113. SAMARAS A, Papazoglou AS, Balomenakis C, Bekiaridou A, et al
    Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis.
    Eur Heart J. 2024;45:214-229.
    >> Share

  114. ORAII A, Healey JS, Kowalik K, Pandey AK, et al
    Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials.
    Eur Heart J. 2024 Jan 9:ehad811. doi: 10.1093.
    >> Share

  115. CARRICK RT, De Marco C, Gasperetti A, Bosman LP, et al
    Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
    Eur Heart J. 2024 Jan 9:ehad799. doi: 10.1093.
    >> Share

  116. LIUZZO G, Patrono C
    Balancing the benefits and risks of anticoagulation in patients with subclinical atrial fibrillation.
    Eur Heart J. 2024 Jan 8:ehad859. doi: 10.1093.
    >> Share

  117. CREA F
    The key role of thrombosis: focus on acute coronary syndrome, venous thrombo-embolism, and atrial fibrillation.
    Eur Heart J. 2024;45:1-4.
    >> Share

  118. PIESZKO K, Hiczkiewicz J, Lojewska K, Uzieblo-Zyczkowska B, et al
    Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry.
    Eur Heart J. 2024;45:32-41.
    >> Share

    December 2023
  119. PROVIDENCIA R, Kukendra-Rajah K, Barra S
    Amiodarone for atrial fibrillation: a dead man walking?
    Eur Heart J. 2023 Dec 29:ehad825. doi: 10.1093.
    >> Share

  120. KRAMARENKO D, Walsh R
    Emery-Dreifuss muscular dystrophy: a closer look at cardiac complications.
    Eur Heart J. 2023;44:5074-5076.
    >> Share

  121. KANAOKA K, Nishida T, Iwanaga Y, Nakai M, et al
    Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks.
    Eur Heart J. 2023 Dec 20:ehad798. doi: 10.1093.
    >> Share

  122. HATALA R, Hlivak P
    Atrial fibrillation in chronic coronary syndromes: a neglected challenge.
    Eur Heart J. 2023 Dec 17:ehad781. doi: 10.1093.
    >> Share

    November 2023
  123. SPOSATO LA, Lip GYH, Haeusler KG
    Atrial fibrillation first detected after stroke: is timing and detection intensity relevant for stroke risk?
    Eur Heart J. 2023 Nov 28:ehad744. doi: 10.1093.
    >> Share

  124. ANJUM M, Ariansen I, Hjellvik V, Selmer R, et al
    Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.
    Eur Heart J. 2023 Nov 23:ehad659. doi: 10.1093.
    >> Share

  125. MARCHLINSKI FE, Oraii A, Muser D
    Anticoagulation for atrial fibrillation in patients with intermediate stroke risk: is the grey zone becoming less grey?
    Eur Heart J. 2023 Nov 23:ehad751. doi: 10.1093.
    >> Share

  126. BECHER N, Toennis T, Bertaglia E, Blomstrom-Lundqvist C, et al
    Anticoagulation with edoxaban in patients with long Atrial High-Rate Episodes >/=24 hours.
    Eur Heart J. 2023 Nov 12:ehad771. doi: 10.1093.
    >> Share

  127. TSABAN G, Ostrovsky D, Alnsasra H, Burrack N, et al
    Amiodarone and pulmonary toxicity in atrial fibrillation: a nationwide Israeli study.
    Eur Heart J. 2023 Nov 6:ehad726. doi: 10.1093.
    >> Share

  128. DEMIDOVA MM, Holmqvist F, Erlinge D, Platonov PG, et al
    Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events.
    Eur Heart J. 2023 Nov 3:ehad740. doi: 10.1093.
    >> Share

  129. INCIARDI RM, Solomon SD
    Beyond the rhythm: atrial fibrillation, diastolic dysfunction, and heart failure.
    Eur Heart J. 2023 Nov 3:ehad747. doi: 10.1093.
    >> Share

    October 2023
  130. ELLIOTT AD, Benjamin EJ, Middeldorp ME
    Prevention of atrial fibrillation: a call to action.
    Eur Heart J. 2023 Oct 31:ehad738. doi: 10.1093.
    >> Share

  131. TILZ RR, Heeger CH
    Be aware and hit hard and early: oesophageal lesions after atrial fibrillation ablation.
    Eur Heart J. 2023 Oct 26:ehad692. doi: 10.1093.
    >> Share

  132. SCANAVACCA M, Pisani C, Rivarola EWR
    Early identification of oesophageal lesions after atrial fibrillation ablation to prevent atrio-oesophageal fistula.
    Eur Heart J. 2023 Oct 26:ehad689. doi: 10.1093.
    >> Share

  133. CREA F
    Innovative trials in heart failure, dyslipidaemias, and sinus node dysfunction.
    Eur Heart J. 2023;44:4203-4207.
    >> Share

  134. PEDICINO D, Volpe M
    Atrial fibrillation ablation improves outcomes in patients with end-stage heart failure: is it all gold the glitter in the CASTLE?
    Eur Heart J. 2023 Oct 17:ehad675. doi: 10.1093.
    >> Share

  135. MARX N, Federici M, Schutt K, Muller-Wieland D, et al
    2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.
    Eur Heart J. 2023;44:4043-4140.
    >> Share

  136. APOSTOLOS A, Aggeli C, Toutouzas K
    Nickel hypersensitivity as the cause of atrial fibrillation after patent foramen ovale closure: fact or myth?
    Eur Heart J. 2023 Oct 4:ehad643. doi: 10.1093.
    >> Share

  137. PAPIOL E, Pastor P, Pueo E
    Skin lesions, weight loss, and ventricular tachycardia: connecting the dots to diagnose multisystemic sarcoidosis.
    Eur Heart J. 2023;44:3705.
    >> Share

    September 2023
  138. LI E, Yan C, Yang X
    Long QT syndrome induced by cervical spondylosis.
    Eur Heart J. 2023 Sep 22:ehad608. doi: 10.1093.
    >> Share

  139. CREA F
    Challenges and opportunities in prognostication: focus on ischaemic heart disease and atrial fibrillation.
    Eur Heart J. 2023;44:3391-3394.
    >> Share

  140. TANAKA Y, Kuroki K, Kaga S
    Life-threatening left atrioesophageal fistula complicated with catheter ablation for atrial fibrillation in a patient with aortic stent graft.
    Eur Heart J. 2023 Sep 19:ehad609. doi: 10.1093.
    >> Share

  141. WANG N, Yu Y, Sun Y, Zhang H, et al
    Acquired risk factors and incident atrial fibrillation according to age and genetic predisposition.
    Eur Heart J. 2023 Sep 19:ehad615. doi: 10.1093.
    >> Share

  142. CREA F
    Focus on atrial fibrillation in specific clinical settings and on calmodulinopathy.
    Eur Heart J. 2023;44:3299-3302.
    >> Share

  143. WANG J, Huang P, Yu Q, Lu J, et al
    Epilepsy and long-term risk of arrhythmias.
    Eur Heart J. 2023;44:3374-3382.
    >> Share

  144. BARSHESHET A, Goldenberg I
    Advancing personalized medicine: the power of collaborative registries of patients with inherited cardiac arrhythmia syndromes.
    Eur Heart J. 2023;44:3371-3373.
    >> Share

  145. CROTTI L, Spazzolini C, Nyegaard M, Overgaard MT, et al
    Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry.
    Eur Heart J. 2023;44:3357-3370.
    >> Share

  146. MOHANTY S, La Fazia VM, Natale A
    The Antwerp score: is this the 'new hope on the horizon'?
    Eur Heart J. 2023;44:3336-3338.
    >> Share

  147. GONG X, Liu JX, Huang XB
    Surgical removal of acoustic neuroma eliminates sick sinus syndrome.
    Eur Heart J. 2023;44:3388.
    >> Share

  148. COURT-KOWALSKI S, McArthur A, Hayres K
    Pulsus paradoxus, electrical alternans, and pulsus alternans in progressive cardiac tamponade.
    Eur Heart J. 2023;44:3297.
    >> Share

  149. MIDDELDORP ME, Sandhu RK
    The stroke enigma: decoding the sex risk factor in atrial fibrillation.
    Eur Heart J. 2023 Sep 6:ehad531. doi: 10.1093.
    >> Share

    August 2023
  150. BUHARI H, Fang J, Han L, Austin PC, et al
    Stroke risk in women with atrial fibrillation.
    Eur Heart J. 2023 Aug 30:ehad508. doi: 10.1093.
    >> Share

  151. CANNIE DE, Syrris P, Protonotarios A, Bakalakos A, et al
    Emery-Dreifuss Muscular Dystrophy 1 is associated with high risk of malignant ventricular arrhythmias and end-stage heart failure.
    Eur Heart J. 2023 Aug 28:ehad561. doi: 10.1093.
    >> Share

  152. NASER JA, Lee E, Scott CG, Kennedy AM, et al
    Prevalence and Incidence of Diastolic Dysfunction in Atrial Fibrillation: Clinical Implications.
    Eur Heart J. 2023 Aug 28:ehad592. doi: 10.1093.
    >> Share

  153. PARKASH R
    Atrial pacing and atrial fibrillation in sinus node dysfunction: a relationship that remains elusive.
    Eur Heart J. 2023 Aug 28:ehad569. doi: 10.1093.
    >> Share

  154. KRONBORG MB, Frausing MHJP, Malczynski J, Riahi S, et al
    Atrial pacing minimization in sinus node dysfunction and risk of incident atrial fibrillation: a randomized trial.
    Eur Heart J. 2023 Aug 28:ehad564. doi: 10.1093.
    >> Share

  155. GAUTIER A, Picard F, Ducrocq G, Elbez Y, et al
    New-onset atrial fibrillation in chronic coronary syndrome: the CLARIFY registry.
    Eur Heart J. 2023 Aug 27:ehad556. doi: 10.1093.
    >> Share

  156. ANDRADE JG, Deyell MW, Khairy P, Champagne J, et al
    Atrial fibrillation progression after cryoablation versus radiofrequency ablation: the CIRCA-DOSE trial.
    Eur Heart J. 2023 Aug 25:ehad572. doi: 10.1093.
    >> Share

  157. MEYRE PB, Conen D
    Adverse outcomes in patients with atrial fibrillation: how previous successes can unmask new challenges.
    Eur Heart J. 2023 Aug 25:ehad575. doi: 10.1093.
    >> Share

  158. WU J, Nadarajah R, Nakao YM, Nakao K, et al
    Temporal trends of cause-specific mortality after diagnosis of atrial fibrillation.
    Eur Heart J. 2023 Aug 25:ehad571. doi: 10.1093.
    >> Share

  159. VERRIER RL, Pang TD, Schachter SC
    Long-term risk for atrial and ventricular arrhythmias: a cardinal manifestation of 'the epileptic heart'.
    Eur Heart J. 2023 Aug 22:ehad524. doi: 10.1093.
    >> Share

  160. KAWAKAMI R, Finn AV, Virmani R
    Histopathology of atrial fibrillation: does this help us understand its pathogenesis?
    Eur Heart J. 2023 Aug 17:ehad515. doi: 10.1093.
    >> Share

  161. OZKAN J
    Barbara Casadei receives award for outstanding research into atrial fibrillation.
    Eur Heart J. 2023 Aug 16:ehad495. doi: 10.1093.
    >> Share

  162. ESSAYAGH B, Sabbag A, El-Am E, Cavalcante JL, et al
    Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management.
    Eur Heart J. 2023 Aug 10:ehad491. doi: 10.1093.
    >> Share

    July 2023
  163. CAMM AJ
    Should the risk of atrial fibrillation deter PFO closure for cryptogenic ischaemic stroke?
    Eur Heart J. 2023 Jul 21:ehad425. doi: 10.1093.
    >> Share

  164. CREA F
    Addressing the pandemic of atrial fibrillation: optimization of catheter ablation and new therapeutic targets.
    Eur Heart J. 2023;44:2413-2416.
    >> Share

  165. WILDE AAM, Amin AS, Morita H, Tadros R, et al
    Use, misuse, and pitfalls of the drug challenge test in the diagnosis of the Brugada syndrome.
    Eur Heart J. 2023;44:2427-2439.
    >> Share

  166. SUDO K, Kuroki K, Sato A
    Dynamical improvement after rescue balloon angioplasty for pulmonary vein occlusion complicated with radiofrequency catheter ablation.
    Eur Heart J. 2023;44:2498.
    >> Share

  167. MARCUS GM
    Translating HARMS2-AF into benefits for our atrial fibrillation patients and the general public: challenges and opportunities.
    Eur Heart J. 2023 Jul 5:ehad423. doi: 10.1093.
    >> Share

  168. PEDICINO D, Volpe M
    Coffee drinking and cardiac ectopic beats: Black or White?
    Eur Heart J. 2023;44:2275-2276.
    >> Share

    June 2023
  169. BERGONTI M, Ascione C, Marcon L, Pambrun T, et al
    Left ventricular functional recovery after atrial fibrillation catheter ablation in heart failure: a prediction model.
    Eur Heart J. 2023 Jun 30:ehad428. doi: 10.1093.
    >> Share

  170. DOUGHERTY S, Nascimento B, Okello E
    Oral anticoagulation for atrial fibrillation in rheumatic heart disease.
    Eur Heart J. 2023 Jun 29:ehad390. doi: 10.1093.
    >> Share

  171. TAKAHASHI Y, Yamaguchi T, Otsubo T, Nakashima K, et al
    Histological validation of atrial structural remodelling in patients with atrial fibrillation.
    Eur Heart J. 2023 Jun 23:ehad396. doi: 10.1093.
    >> Share

  172. SEGAN L, Canovas R, Nanayakkara S, Chieng D, et al
    New-onset atrial fibrillation prediction: the HARMS2-AF risk score.
    Eur Heart J. 2023 Jun 23:ehad375. doi: 10.1093.
    >> Share

  173. METZNER A, Kirchhof P
    Good rhythm control without haste: atrial fibrillation ablation remains effective after a year of waiting.
    Eur Heart J. 2023 Jun 22:ehad393. doi: 10.1093.
    >> Share

  174. LIM MW, Kalman JM
    Putting fear into perspective: estimating the true incidence of oesophageal fistula formation post-atrial fibrillation ablation.
    Eur Heart J. 2023 Jun 8:ehad309. doi: 10.1093.
    >> Share

  175. SKIBSTED CV, Korsholm K, Pedersen L, Bonnesen K, et al
    Long-term risk of atrial fibrillation or flutter after transcatheter patent foramen ovale closure: a nationwide Danish study.
    Eur Heart J. 2023 Jun 3:ehad305. doi: 10.1093.
    >> Share

    May 2023
  176. LEHTONEN J, Uusitalo V, Poyhonen P, Mayranpaa MI, et al
    Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis.
    Eur Heart J. 2023;44:1495-1510.
    >> Share

    April 2023
  177. LEE J, Kim JS, Shim CY
    MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
    Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093.
    >> Share

  178. TILZ RR, Schmidt V, Purerfellner H, Maury P, et al
    A worldwide survey on incidence, management and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: The POTTER-AF study.
    Eur Heart J. 2023 Apr 16:ehad250. doi: 10.1093.
    >> Share

  179. KALMAN JM, Al-Kaisey AM, Parameswaran R, Hawson J, et al
    Impact of Early Versus Delayed Atrial Fibrillation Catheter Ablation on Atrial Arrhythmia Recurrences.
    Eur Heart J. 2023 Apr 16:ehad247. doi: 10.1093.
    >> Share

  180. HAEUSLER KG
    Ischaemic stroke in atrial fibrillation patients while on oral anticoagulation-a call for A-C-T-I-O-N.
    Eur Heart J. 2023 Apr 11:ehad203. doi: 10.1093.
    >> Share

  181. BENZ AP, Hohnloser SH, Eikelboom JW, Carnicelli AP, et al
    Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.
    Eur Heart J. 2023 Apr 11:ehad200. doi: 10.1093.
    >> Share

  182. RENNISON JH, Van Wagoner DR
    Dysregulated Ca2+ cycling in atrial fibrillation.
    Eur Heart J. 2023 Apr 4:ehad099. doi: 10.1093.
    >> Share

    March 2023
  183. FRIMODT-MOLLER EK, Soliman EZ, Kizer JR, Vittinghoff E, et al
    Lifestyle habits associated with cardiac conduction disease.
    Eur Heart J. 2023;44:1058-1066.
    >> Share

  184. NOUBIAP JJ, Middeldorp ME
    Prevention of cardiac conduction disease: a long way to go.
    Eur Heart J. 2023;44:1067-1069.
    >> Share

  185. THIELE H, Desch S, Freund A
    Out-of-hospital cardiac arrest without ST-segment elevation: an alternative focus on priorities?
    Eur Heart J. 2023;44:1055-1057.
    >> Share

  186. CREA F
    Cardiovascular diseases in pregnancy, congenital heart disease, and arrhythmias: lessons from epidemiology.
    Eur Heart J. 2023;44:699-702.
    >> Share

  187. AL-KAISEY AM, Kalman JM
    Atrial arrhythmia recurrence post-catheter ablation: when perfect is the enemy of good.
    Eur Heart J. 2023;44:777-779.
    >> Share

    February 2023
  188. GRAMMATIKA PAVLIDOU N, Dobrev S, Beneke K, Reinhardt F, et al
    Phosphodiesterase 8 governs cAMP/PKA-dependent reduction of L-type calcium current in human atrial fibrillation: a novel arrhythmogenic mechanism.
    Eur Heart J. 2023 Feb 22:ehad086. doi: 10.1093.
    >> Share

  189. LIU X, Luo H, Qin X
    Vanishing 'table tennis': a case of active left atrial thrombus.
    Eur Heart J. 2023;44:698.
    >> Share

  190. WOUTERS PC, van de Leur RR, Vessies MB, van Stipdonk AMW, et al
    Electrocardiogram-based deep learning improves outcome prediction following cardiac resynchronization therapy.
    Eur Heart J. 2023;44:680-692.
    >> Share

  191. LAMBIASE PD, Sanders P, Crijns HJGM
    The year in cardiovascular medicine 2022: the top 10 papers in arrhythmias.
    Eur Heart J. 2023;44:345-347.
    >> Share

    January 2023
  192. GAUDINO M, Di Franco A, Rong LQ, Piccini J, et al
    Postoperative atrial fibrillation: from mechanisms to treatment.
    Eur Heart J. 2023 Jan 31:ehad019. doi: 10.1093.
    >> Share

  193. BUTCHER SC, Essayagh B, Steyerberg EW, Benfari G, et al
    Factors influencing post-surgical survival in degenerative mitral regurgitation.
    Eur Heart J. 2023 Jan 26:ehad004. doi: 10.1093.
    >> Share


  194. Corrigendum to: Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
    Eur Heart J. 2023 Jan 24:ehad045. doi: 10.1093.
    >> Share

  195. KANAMURA T, Hashimoto T, Shiose A, Tsutsui H, et al
    Thrombus associated with locked-in atrial fibrillation in recipient remnant left atrium after heart transplantation.
    Eur Heart J. 2023 Jan 20:ehad008. doi: 10.1093.
    >> Share

  196. NARDUCCI ML, Pedicino D
    A new defibrillation strategy for refractory ventricular fibrillation during out-of-hospital cardiac arrest: are two better than one?
    Eur Heart J. 2023 Jan 20:ehad002. doi: 10.1093.
    >> Share

  197. WALDMANN V, Barra S, Marijon E
    Ventricular arrhythmias and sudden cardiac death in heart failure with mildly reduced or preserved ejection fraction: knowledge gaps.
    Eur Heart J. 2023 Jan 20:ehad001. doi: 10.1093.
    >> Share

  198. CREA F
    Management of atrial fibrillation: role of population screening, biomarkers, and polygenic risk scores.
    Eur Heart J. 2023;44:167-170.
    >> Share

  199. CURTAIN JP, Adamson C, Kondo T, Butt J, et al
    Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
    Eur Heart J. 2023 Jan 12:ehac801. doi: 10.1093.
    >> Share

  200. ACHA MR, Glikson M
    Type 2 diabetes mellitus association with atrioventricular block.
    Eur Heart J. 2023 Jan 7:ehac755. doi: 10.1093.
    >> Share

    December 2022
  201. LIUZZO G, Patrono C
    Vitamin K antagonists remain the INVICTUS standard of care for patients with rheumatic heart disease and atrial fibrillation.
    Eur Heart J. 2022 Dec 17:ehac721. doi: 10.1093.
    >> Share

  202. MATUSIK PS, Matusik PT, Stein PK
    Heart rate variability and heart rate patterns measured from wearable and implanted devices in screening for atrial fibrillation: potential clinical and population-wide applications.
    Eur Heart J. 2022 Dec 17:ehac546. doi: 10.1093.
    >> Share

  203. CREA F
    Novel risk factors for atrial fibrillation, conduction disturbances, sudden coronary death, and device infection.
    Eur Heart J. 2022;43:4853-4857.
    >> Share

  204. LAZZERINI PE, Boutjdir M, Capecchi PL
    Anti-Ro/SSA-antibodies and heart rhythm disturbances in the general population: the 'dark side of the immune'.
    Eur Heart J. 2022;43:4920-4922.
    >> Share

  205. AKUKA A, Ben-Shabat N, Watad A, Tsur AM, et al
    Association of anti-Ro seropositivity with cardiac rhythm and conduction disturbances.
    Eur Heart J. 2022;43:4912-4919.
    >> Share

  206. TFELT-HANSEN J, Winkel BG, de Riva M, Zeppenfeld K, et al
    The '10 commandments' for the 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
    Eur Heart J. 2022 Dec 7:ehac699. doi: 10.1093.
    >> Share

  207. O'SULLIVAN JW, Ashley EA, Elliott PM
    Polygenic risk scores for the prediction of cardiometabolic disease.
    Eur Heart J. 2022 Dec 7:ehac648. doi: 10.1093.
    >> Share

  208. ANDREOTTI F, Geisler T, Collet JP, Gigante B, et al
    Acute, periprocedural and longterm antithrombotic therapy in older adults.
    Eur Heart J. 2022 Dec 7:ehac515. doi: 10.1093.
    >> Share

  209. ANDRADE JG, Deyell MW, Macle L, Steinberg JS, et al
    Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study.
    Eur Heart J. 2022 Dec 2:ehac692. doi: 10.1093.
    >> Share

  210. SPATZ ES, Herrin J
    Screening for atrial fibrillation to prevent stroke: increasing enthusiasm but outcomes still lag.
    Eur Heart J. 2022 Dec 2:ehac696. doi: 10.1093.
    >> Share

  211. OSMANCIK P, Widimsky P
    Left atrial appendage occluders-new hope for stroke prevention in high-risk patients.
    Eur Heart J. 2022;43:4669-4671.
    >> Share

    November 2022
  212. HAXHA S, Halili A, Malmborg M, Pedersen-Bjergaard U, et al
    Type 2 diabetes mellitus and higher rate of complete atrioventricular block: a Danish Nationwide Registry.
    Eur Heart J. 2022 Nov 26:ehac662. doi: 10.1093.
    >> Share

  213. KU L, Chen Y, Ma X
    Pericardial-esophageal fistula caused by radiofrequency ablation for atrial fibrillation.
    Eur Heart J. 2022 Nov 22:ehac673. doi: 10.1093.
    >> Share

  214. SINNER MF, von Falkenhausen AS
    A specific new biomarker for atrial fibrillation and its sequelae?
    Eur Heart J. 2022 Nov 18. pii: 6833208. doi: 10.1093.
    >> Share

  215. GOLDENBERG L, Huang DT
    Subcutaneous implantable cardioverter defibrillator for the prevention of sudden cardiac death: ready for prime-time?
    Eur Heart J. 2022 Nov 16. pii: 6830653. doi: 10.1093.
    >> Share

  216. HIJAZI Z, Benz AP, Lindback J, Alexander JH, et al
    Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation.
    Eur Heart J. 2022 Nov 16. pii: 6830621. doi: 10.1093.
    >> Share

  217. HARRINGTON J, Granger CB
    Bleeding and risk for future cardiovascular events in patients with atrial fibrillation on oral anticoagulation: major bleeding is a major problem.
    Eur Heart J. 2022 Nov 16. pii: 6830575. doi: 10.1093.
    >> Share

  218. HOLMSTROM L, Chugh SS
    How to minimize in-hospital mortality from acute myocardial infarction: focus on primary prevention of ventricular fibrillation.
    Eur Heart J. 2022 Nov 15. pii: 6827956. doi: 10.1093.
    >> Share

  219. LYTH J, Svennberg E, Bernfort L, Aronsson M, et al
    Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study.
    Eur Heart J. 2022 Nov 9. pii: 6806218. doi: 10.1093.
    >> Share

    October 2022
  220. GARCIA R, Marijon E, Karam N, Narayanan K, et al
    Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study.
    Eur Heart J. 2022 Oct 28. pii: 6776117. doi: 10.1093.
    >> Share

  221. MEYRE PB, Blum S, Hennings E, Aeschbacher S, et al
    Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing.
    Eur Heart J. 2022 Oct 26. pii: 6773770. doi: 10.1093.
    >> Share

  222. GAWALKO M, Sanders P
    Drug abuse and risk of atrial fibrillation: a neglected association.
    Eur Heart J. 2022 Oct 26. pii: 6774408. doi: 10.1093.
    >> Share

  223. YANG Y, Xie L, Qian H, Cui K, et al
    Minimally invasive videoscope-assisted cardiac surgery for paroxysmal atrial tachycardia originating from right atrial appendage.
    Eur Heart J. 2022 Oct 26. pii: 6774389. doi: 10.1093.
    >> Share

  224. KAAB S, Holm H, Kirchhof P
    Genomic risk scores, biomolecules, and clinical conditions to predict atrial fibrillation: time to integrate what we can measure.
    Eur Heart J. 2022 Oct 21. pii: 6767860. doi: 10.1093.
    >> Share

  225. CREA F
    New tools to predict and new therapeutic targets to treat life-threatening ventricular arrhythmias.
    Eur Heart J. 2022;43:3983-3986.
    >> Share

  226. BRIGNOLE M, Sutton R
    Left bundle branch area pacing in perspective.
    Eur Heart J. 2022;43:4174-4176.
    >> Share

  227. LINZ D, McIntyre WF
    Sinus rhythm: the sine qua non for rhythm control?
    Eur Heart J. 2022;43:4145-4147.
    >> Share

  228. JASTRZEBSKI M, Kielbasa G, Cano O, Curila K, et al
    Left bundle branch area pacing outcomes: the multicentre European MELOS study.
    Eur Heart J. 2022;43:4161-4173.
    >> Share

  229. VANDEWIELE F, Pironet A, Jacobs G, Kecskes M, et al
    TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmias.
    Eur Heart J. 2022;43:4195-4207.
    >> Share

  230. HEIJMAN J, Dobrev D
    Molecular determinants and therapeutic potential of focal ectopic activity: more than meets the Iti.
    Eur Heart J. 2022;43:4208-4210.
    >> Share

  231. TORBATI T, Shufelt C, Wei J, Noel Bairey Merz C, et al
    Premature menopause and cardiovascular disease: can we blame estrogen?
    Eur Heart J. 2022;43:4158-4160.
    >> Share

  232. MONDA E, Lioncino M, Limongelli G
    Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: the challenge of complex statistical modelling and its impact in clinical practice.
    Eur Heart J. 2022 Oct 20. pii: 6763998. doi: 10.1093.
    >> Share

  233. CADRIN-TOURIGNY J, Bosman LP, James CA
    Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: a practical approach to navigating the challenges of prediction models.
    Eur Heart J. 2022 Oct 20. pii: 6764102. doi: 10.1093.
    >> Share

  234. LIN AL, Nah G, Tang JJ, Vittinghoff E, et al
    Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation.
    Eur Heart J. 2022 Oct 18. pii: 6754793. doi: 10.1093.
    >> Share

  235. LI J
    Long QT syndrome: long story short.
    Eur Heart J. 2022 Oct 18. pii: 6762505. doi: 10.1093.
    >> Share

  236. XIAO Q, Pu X, Wei X, Chen M, et al
    Refractory cardiogenic shock in a senile atrial fibrillation patient after left atrial appendage occlusion.
    Eur Heart J. 2022 Oct 17. pii: 6761762. doi: 10.1093.
    >> Share

    September 2022
  237. NABETA T, Kitai T, Naruse Y, Taniguchi T, et al
    Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry.
    Eur Heart J. 2022;43:3450-3459.
    >> Share

  238. MA S, Jiang J
    Pulmonary vein stenosis stenting in a patient with persistent left superior vena cava after atrial fibrillation ablation.
    Eur Heart J. 2022 Sep 16. pii: 6701795. doi: 10.1093.
    >> Share


  239. Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
    Eur Heart J. 2022 Sep 15. pii: 6701590. doi: 10.1093.
    >> Share

  240. KOVACS B, Mayinger M, Andratschke N, Saguner AM, et al
    Stereotactic arrhythmia radioablation: competitor or adjunct to catheter ablation?
    Eur Heart J. 2022;43:3279-3281.
    >> Share

    August 2022
  241. SMEDSRUD MK, Chivulescu M, Forsa MI, Castrini I, et al
    Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Aug 29. pii: 6676380. doi: 10.1093.
    >> Share

  242. ECKARDT L, Sehner S, Suling A, Borof K, et al
    Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST - AFNET 4 trial.
    Eur Heart J. 2022 Aug 29. pii: 6675568. doi: 10.1093.
    >> Share

  243. KONDO T, Abdul-Rahim AH, Talebi A, Abraham WT, et al
    Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
    Eur Heart J. 2022 Aug 26. pii: 6676501. doi: 10.1093.
    >> Share

  244. ZEPPENFELD K, Tfelt-Hansen J, de Riva M, Winkel BG, et al
    2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
    Eur Heart J. 2022 Aug 26. pii: 6675633. doi: 10.1093.
    >> Share

  245. SAGRIS D, Shantsila E, Lip GYH
    Stroke risk stratification in patients with heart failure and sinus rhythm.
    Eur Heart J. 2022 Aug 26. pii: 6676507. doi: 10.1093.
    >> Share

  246. CHEN Q, Sen B, Feng X, Yang Q, et al
    Catastrophic atrial tachycardia-induced cardiomyopathy in a teenager treated by extracorporeal membrane oxygenation and stereotactic arrhythmia radioablation.
    Eur Heart J. 2022;43:3086.
    >> Share

  247. CORRADO D, Link MS, Schwartz PJ
    Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?
    Eur Heart J. 2022;43:3029-3040.
    >> Share

  248. GRONDIN S, Davies B, Cadrin-Tourigny J, Steinberg C, et al
    Importance of genetic testing in unexplained cardiac arrest.
    Eur Heart J. 2022;43:3071-3081.
    >> Share

  249. HUQI A, Zoccali C, Giugliano RP, De Caterina R, et al
    Safety of non-vitamin K antagonist oral anticoagulants: concerns in patients with atrial fibrillation and glomerular hyperfiltration?
    Eur Heart J. 2022 Aug 19. pii: 6671685. doi: 10.1093.
    >> Share

  250. MARSTON NA, Garfinkel AC, Kamanu FK, Melloni GM, et al
    A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
    Eur Heart J. 2022 Aug 18. pii: 6671409. doi: 10.1093.
    >> Share

  251. NARDUCCI ML, Volpe M
    Atrial fibrosis detected by cardiac magnetic resonance in persistent atrial fibrillation: a useful risk stratifier but not ideal electrophysiological endpoint for catheter ablation.
    Eur Heart J. 2022 Aug 8. pii: 6658237. doi: 10.1093.
    >> Share


  252. Corrigendum to: Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
    Eur Heart J. 2022 Aug 5. pii: 6656112. doi: 10.1093.
    >> Share

  253. DE CATERINA R, Agewall S, Andreotti F, Angiolillo DJ, et al
    Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
    Eur Heart J. 2022 Aug 4. pii: 6655770. doi: 10.1093.
    >> Share

  254. SHIN J, Han K, Jung JH, Park HJ, et al
    Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2022 Aug 4. pii: 6646730. doi: 10.1093.
    >> Share

    July 2022
  255. KHAIRY P
    Sudden cardiac death in adults with transposition of the great arteries and systemic right ventricles: preventing (night)MAREs.
    Eur Heart J. 2022;43:2695-2697.
    >> Share

  256. BRIDA M, Chessa M, Celermajer D, Li W, et al
    Atrial septal defect in adulthood: a new paradigm for congenital heart disease.
    Eur Heart J. 2022;43:2660-2671.
    >> Share


  257. Corrigendum to: Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias.
    Eur Heart J. 2022 Jul 8. pii: 6633850. doi: 10.1093.
    >> Share

  258. LIP GYH, Lane DA, Lenarczyk R, Boriani G, et al
    Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.
    Eur Heart J. 2022;43:2442-2460.
    >> Share

    June 2022
  259. PROTONOTARIOS A, Bariani R, Cappelletto C, Pavlou M, et al
    Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619317. doi: 10.1093.
    >> Share

  260. JORDA P, Bosman LP, Gasperetti A, Mazzanti A, et al
    Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619318. doi: 10.1093.
    >> Share

  261. GANDJBAKHCH E, Vischer AS
    Arrhythmogenic right ventricular cardiomyopathy: the never-ending quest for a risk calculator.
    Eur Heart J. 2022 Jun 29. pii: 6619319. doi: 10.1093.
    >> Share

  262. GOYAL P, Kim M, Krishnan U, Mccullough SA, et al
    Post-operative atrial fibrillation and risk of heart failure hospitalization.
    Eur Heart J. 2022 Jun 28. pii: 6617280. doi: 10.1093.
    >> Share

  263. MIDDELDORP ME, Albert CM
    Post-operative AF and heart failure hospitalizations: what remains hidden in patients undergoing surgery.
    Eur Heart J. 2022 Jun 28. pii: 6617281. doi: 10.1093.
    >> Share

  264. NINNI S, Longere B, Mirabel X
    Stereotactic radioablation to treat ventricular tachycardia related to a left ventricular mass.
    Eur Heart J. 2022;43:2341.
    >> Share


  265. Erratum to: Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
    Eur Heart J. 2022 Jun 18. pii: 6610027. doi: 10.1093.
    >> Share

  266. WEI X, Zhou M, Chen Y, Chen M, et al
    Paroxysmal massive mitral regurgitation.
    Eur Heart J. 2022 Jun 17. pii: 6609956. doi: 10.1093.
    >> Share

  267. CREA F
    The complex link among heart failure, atrial fibrillation, and lung diseases, and an update on cardiac transplantation.
    Eur Heart J. 2022;43:2165-2169.
    >> Share

  268. LADOUCEUR M, Van De Bruaene A, Kauling R, Budts W, et al
    A new score for life-threatening ventricular arrhythmias and sudden cardiac death in adults with transposition of the great arteries and a systemic right ventricle.
    Eur Heart J. 2022 Jun 8. pii: 6604048. doi: 10.1093.
    >> Share

  269. CACHEUX M, Akar FG
    A novel exosome-based therapy for post-MI arrhythmias.
    Eur Heart J. 2022;43:2157-2159.
    >> Share

  270. BRIGNOLE M, Soranna D, Rienstra M
    Is APAF-CRT robust enough to change clinical practice?
    Eur Heart J. 2022;43:2161-2162.
    >> Share

  271. PABEL S, Sossalla S
    Atrial fibrillation and heart failure: novel insights into the chicken and egg dilemma.
    Eur Heart J. 2022 Jun 2. pii: 6599046. doi: 10.1093.
    >> Share

    May 2022
  272. JOHNSEN SP, Proietti M, Maggioni AP, Lip GYH, et al
    A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO Consortium.
    Eur Heart J. 2022 May 22. pii: 6590386. doi: 10.1093.
    >> Share

  273. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
    Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1955-1969.
    >> Share

  274. REMME CA, Leclercq C, Behr ER
    The European Cardiac Arrhythmia Genetics (ECGen) Focus Group.
    Eur Heart J. 2022;43:1891-1894.
    >> Share

  275. LIUZZO G, Patrono C
    A novel inhibitor of Factor XIa as potential haemostasis-sparing anticoagulant for patients with atrial fibrillation.
    Eur Heart J. 2022 May 13. pii: 6585115. doi: 10.1093.
    >> Share

  276. KANY S, Metzner A, Lubos E, Kirchhof P, et al
    The Atrial Fibrillation Heart Team-guiding therapy in left atrial appendage occlusion with increasingly complex patients and little evidence.
    Eur Heart J. 2022;43:1691-1692.
    >> Share

  277. CARRION-SANCHEZ I, Cobos-Gil MA
    Electrical alternans detected by an Apple Watch.
    Eur Heart J. 2022;43:1775.
    >> Share

    April 2022
  278. ODENING KE, van der Linde HJ, Ackerman MJ, Volders PGA, et al
    Electromechanical reciprocity and arrhythmogenesis in long-QT syndrome and beyond.
    Eur Heart J. 2022 Apr 21. pii: 6571781. doi: 10.1093.
    >> Share


  279. Corrigendum to: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Apr 20. pii: 6569859. doi: 10.1093.
    >> Share

  280. VAN DER MEER P, Rienstra M, van Veldhuisen DJ
    A deleterious interaction between omecamtiv mecarbil and atrial fibrillation in patients with heart failure: an influence of digoxin?
    Eur Heart J. 2022 Apr 20. pii: 6571185. doi: 10.1093.
    >> Share

  281. CADRIN-TOURIGNY J, Bosman LP, Nozza A, Wang W, et al
    A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Eur Heart J. 2022 Apr 20. pii: 6569858. doi: 10.1093.
    >> Share

  282. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    >> Share

  283. STIEGLIS R, Zijlstra JA, Riedijk F, Smeekes M, et al
    Alert system-supported lay defibrillation and basic life-support for cardiac arrest at home.
    Eur Heart J. 2022;43:1465-1474.
    >> Share

  284. FERNANDEZ ASENSIO R, Pascual Calleja I, Moris de la Tassa C, Colunga Blanco S, et al
    Pneumopericardium mimicking ST-segment elevation acute coronary syndrome.
    Eur Heart J. 2022;43:1516.
    >> Share

    March 2022
  285. SANDHU A, Varosy PD
    Left atrial appendage occlusion in patients unable to tolerate anticoagulation is cost-effective in Sweden: but how generalizable is this finding?
    Eur Heart J. 2022;43:1357-1359.
    >> Share

  286. SOLOMON SD, Claggett BL, Miao ZM, Diaz R, et al
    Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
    Eur Heart J. 2022 Mar 23. pii: 6552734. doi: 10.1093.
    >> Share

  287. CREA F
    Novel mechanistic insights into ventricular arrhythmias and sudden death.
    Eur Heart J. 2022;43:1177-1180.
    >> Share

  288. CRIJNS HJGM, Sanders P, Albert CM, Lambiase PD, et al
    The year in cardiovascular medicine 2021: arrhythmias.
    Eur Heart J. 2022;43:1191-1197.
    >> Share

  289. CASTILHO BM, Domingues K, Damasio AF
    Pacemaker malcapture and wide QRS complexes.
    Eur Heart J. 2022;43:1272.
    >> Share

  290. SCHWARTZ PJ, Ackerman MJ
    Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias.
    Eur Heart J. 2022 Mar 18. pii: 6550339. doi: 10.1093.
    >> Share

  291. SLATER NR, Murphy KR, Sikkel MB
    VT storm in long QT resulting from COVID-19 vaccine allergy treated with epinephrine.
    Eur Heart J. 2022;43:1176.
    >> Share

  292. MCINTYRE WF, Linz D
    Atrial fibrillation and stroke: who is low risk and what are we going to do about it?
    Eur Heart J. 2022 Mar 10. pii: 6546014. doi: 10.1093.
    >> Share

  293. KOMEN JJ, Pottegard A, Mantel-Teeuwisse AK, Forslund T, et al
    Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.
    Eur Heart J. 2022 Mar 10. pii: 6546013. doi: 10.1093.
    >> Share

  294. PRINZEN FW, Auricchio A, Mullens W, Linde C, et al
    Electrical management of heart failure: from pathophysiology to treatment.
    Eur Heart J. 2022 Mar 10. pii: 6546052. doi: 10.1093.
    >> Share

  295. DAWKINS JF, Ehdaie A, Rogers R, Soetkamp D, et al
    Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy.
    Eur Heart J. 2022 Mar 9. pii: 6545456. doi: 10.1093.
    >> Share

  296. MEHILLI J, Winhard M
    The CHADS-P2A2RC score: ready to guide the selection of treatment?
    Eur Heart J. 2022;43:1005-1007.
    >> Share

  297. NASSER R, Meyten N, Vermeersch P, Prihadi EA, et al
    When the solution becomes the problem: left atrial appendage occlusion device-related thrombus after 5 years.
    Eur Heart J. 2022;43:1015.
    >> Share

    February 2022
  298. KAUR H, McIntyre WF, Belley-Cote EP
    Ablate and pace for patients with atrial fibrillation: a fragile option?
    Eur Heart J. 2022 Feb 21. pii: 6533261. doi: 10.1093.
    >> Share

  299. JARED BUNCH T, Steinberg BA
    Clinical strokes in atrial fibrillation: the tip of the iceberg.
    Eur Heart J. 2022 Feb 18. pii: 6532261. doi: 10.1093.
    >> Share

  300. KUHNE M, Krisai P, Coslovsky M, Rodondi N, et al
    Silent brain infarcts impact on cognitive function in atrial fibrillation.
    Eur Heart J. 2022 Feb 17. pii: 6529516. doi: 10.1093.
    >> Share

  301. MUTAGAYWA RK, Chin A, Karaye K, Bonny A, et al
    Unmet needs in the management of arrhythmias among heart failure patients in Africa.
    Eur Heart J. 2022 Feb 15. pii: 6528559. doi: 10.1093.
    >> Share

  302. TAGGART P, Nash MP, Lambiase P
    Ventricular fibrillation: combined myocardial substrate and Purkinje ablation.
    Eur Heart J. 2022 Feb 9. pii: 6525334. doi: 10.1093.
    >> Share

  303. HAISSAGUERRE M, Cheniti G, Hocini M, Sacher F, et al
    Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation.
    Eur Heart J. 2022 Feb 3. pii: 6521660. doi: 10.1093.
    >> Share

    January 2022
  304. CREA F
    Cardio-oncology: a focus on cardiovascular toxicities of cancer therapies and on atrial fibrillation in cancer.
    Eur Heart J. 2022;43:245-248.
    >> Share

  305. NARDUCCI ML, Volpe M
    Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP study.
    Eur Heart J. 2022;43:261-262.
    >> Share

  306. NOUBIAP JJ
    The association of atrial fibrillation with mortality in patients with breast cancer.
    Eur Heart J. 2022 Jan 28. pii: 6516864. doi: 10.1093.
    >> Share

  307. LAMBIASE PD, Theuns DA, Murgatroyd F, Barr C, et al
    Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study.
    Eur Heart J. 2022 Jan 28. pii: 6516831. doi: 10.1093.
    >> Share

  308. GUHA A, Alonso A, Addison D
    The association of atrial fibrillation with mortality in patients with breast cancer: author reply.
    Eur Heart J. 2022 Jan 28. pii: 6516863. doi: 10.1093.
    >> Share

  309. BENFARI G, Sorajja P, Pedrazzini G, Taramasso M, et al
    Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation.
    Eur Heart J. 2022 Jan 28. pii: 6516827. doi: 10.1093.
    >> Share

  310. NICHOLLS M
    Preventing stroke in atrial fibrillation patients.
    Eur Heart J. 2022 Jan 25. pii: 6515302. doi: 10.1093.
    >> Share


  311. Corrigendum to: Incidence, Risk Factors and Mortality of Atrial Fibrillation in Breast Cancer: A SEER-Medicare Analysis.
    Eur Heart J. 2022 Jan 12. pii: 6505260. doi: 10.1093.
    >> Share

    December 2021

  312. Erratum to: Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
    Eur Heart J. 2021 Dec 21. pii: 6472922. doi: 10.1093.
    >> Share

  313. NICHOLLS M
    Making connections to overcome arrhythmias.
    Eur Heart J. 2021;42:4878-4880.
    >> Share

  314. LABORI F, Persson J, Bonander C, Jood K, et al
    Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation.
    Eur Heart J. 2021 Dec 17. pii: 6468857. doi: 10.1093.
    >> Share

  315. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
    Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Eur Heart J. 2021 Dec 8. pii: 6456446. doi: 10.1093.
    >> Share

  316. CREA F
    Management of arrhythmias: the increasing role of artificial intelligence, genetics and cardiac resyncronization.
    Eur Heart J. 2021;42:4703-4706.
    >> Share

  317. ATTIA ZI, Harmon DM, Behr ER, Friedman PA, et al
    Application of artificial intelligence to the electrocardiogram.
    Eur Heart J. 2021;42:4717-4730.
    >> Share

  318. HATALA R
    Rhythm control in asymptomatic 'early' atrial fibrillation: birth of a new paradigm?
    Eur Heart J. 2021 Dec 2. pii: 6448252. doi: 10.1093.
    >> Share

    November 2021
  319. BOR WL, Ten Berg JM
    Known or new atrial fibrillation in patients with acute coronary syndrome: what's the difference?
    Eur Heart J. 2021;42:4562-4564.
    >> Share

  320. AHLBERG G, Andreasen L, Ghouse J, Bertelsen L, et al
    Genome-wide association study identifies 18 novel loci associated with left atrial volume and function.
    Eur Heart J. 2021;42:4523-4534.
    >> Share

  321. CERRONE M, Marron-Linares GM, van Opbergen CJM, Costa S, et al
    Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study.
    Eur Heart J. 2021 Nov 19. pii: 6431860. doi: 10.1093.
    >> Share

  322. MERINO JL
    Atrial fibrillation and breast cancer: Casual or causal relationship?
    Eur Heart J. 2021 Nov 14. pii: 6427544. doi: 10.1093.
    >> Share

  323. GUHA A, Fradley MG, Dent SF, Weintraub NL, et al
    Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis.
    Eur Heart J. 2021 Nov 14. pii: 6427396. doi: 10.1093.
    >> Share

    October 2021
  324. HEIDBUCHEL H, Van Gelder IC, Desteghe L
    ESC and EHRA lead a path towards integrated care for multimorbid atrial fibrillation patients: the Horizon 2020 EHRA-PATHS project.
    Eur Heart J. 2021 Oct 25. pii: 6409895. doi: 10.1093.
    >> Share

  325. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
    Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Eur Heart J. 2021 Oct 16. pii: 6398359. doi: 10.1093.
    >> Share

  326. LUSCHER TF, Davies A, Beer JH, Valgimigli M, et al
    Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum.
    Eur Heart J. 2021 Oct 8. pii: 6384672. doi: 10.1093.
    >> Share

  327. NAGARAJAN VD, Lee SL, Robertus JL, Nienaber CA, et al
    Artificial intelligence in the diagnosis and management of arrhythmias.
    Eur Heart J. 2021;42:3904-3916.
    >> Share

  328. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
    Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:3932-3944.
    >> Share

  329. CREA F
    The growing role of artificial intelligence and of wearable devices in the management of arrhythmias.
    Eur Heart J. 2021;42:3889-3893.
    >> Share

  330. GARG L, Fradley MG
    QT prolongation and cancer therapeutics: a coming Tempest or Much Ado About Nothing?
    Eur Heart J. 2021;42:3929-3931.
    >> Share

  331. VAN DER WERF C, Lambiase PD
    Initiation and management of polymorphic ventricular tachycardia: history gone full circle.
    Eur Heart J. 2021;42:3976-3978.
    >> Share

  332. ROSSO R, Hochstadt A, Viskin D, Chorin E, et al
    Polymorphic ventricular tachycardia, ischaemic ventricular fibrillation, and torsade de pointes: importance of the QT and the coupling interval in the differential diagnosis.
    Eur Heart J. 2021;42:3965-3975.
    >> Share

  333. LINDE C
    Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial.
    Eur Heart J. 2021 Oct 6. pii: 6382271. doi: 10.1093.
    >> Share

    September 2021
  334. RUSSO AM
    Alcohol intake and risk of stroke in atrial fibrillation: the lesser the better, but this is not enough.
    Eur Heart J. 2021 Sep 30. pii: 6378270. doi: 10.1093.
    >> Share

  335. WALSH R, Adler A, Amin AS, Abiusi E, et al
    Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death.
    Eur Heart J. 2021 Sep 24. pii: 6374783. doi: 10.1093.
    >> Share

  336. TINKER A
    Does knowledge of the mutation in hereditary long QT syndrome aid risk stratification?
    Eur Heart J. 2021 Sep 20. pii: 6372801. doi: 10.1093.
    >> Share

  337. CREA F
    The ESC Guidelines on cardiac pacing and resynchronization, and the many facets of atrial fibrillation.
    Eur Heart J. 2021;42:3411-3414.
    >> Share

  338. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
    Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrill
    Eur Heart J. 2021 Sep 14. pii: 6370283. doi: 10.1093.
    >> Share

  339. GLIKSON M, Nielsen JC, Kronborg MB, Michowitz Y, et al
    2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.
    Eur Heart J. 2021;42:3427-3520.
    >> Share

  340. LIN YN, Mesquita T, Sanchez L, Chen YH, et al
    Extracellular vesicles from immortalized cardiosphere-derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein-2 mutant mice.
    Eur Heart J. 2021;42:3558-3571.
    >> Share

  341. SCHWARTZ PJ, Tan HL
    Long QT syndrome, artificial intelligence, and common sense.
    Eur Heart J. 2021 Sep 11. pii: 6368899. doi: 10.1093.
    >> Share

  342. SCHWARTZ PJ, Moreno C, Kotta MC, Pedrazzini M, et al
    Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region.
    Eur Heart J. 2021 Sep 10. pii: 6368299. doi: 10.1093.
    >> Share

  343. NAUFFAL V, Marstrand P, Han L, Parikh VN, et al
    Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
    Eur Heart J. 2021 Sep 7. pii: 6365852. doi: 10.1093.
    >> Share

  344. STEINBERG C, Krahn AD
    Quinidine vs. ICD therapy in short-coupled ventricular fibrillation-is a randomized trial the next logical step?
    Eur Heart J. 2021 Sep 4. pii: 6364089. doi: 10.1093.
    >> Share

  345. BELHASSEN B
    Quinidine vs. ICD in patients with short-coupled idiopathic ventricular fibrillation: a call for a multicenter randomized trial.
    Eur Heart J. 2021 Sep 4. pii: 6364083. doi: 10.1093.
    >> Share

  346. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
    Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
    >> Share

  347. BONNESEN MP, Frodi DM, Haugan KJ, Kronborg C, et al
    Day-to-day measurement of physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 Sep 2. pii: 6362464. doi: 10.1093.
    >> Share

  348. PRIFTI E, Fall A, Davogustto G, Pulini A, et al
    Deep learning analysis of electrocardiogram for risk prediction of drug-induced arrhythmias and diagnosis of long QT syndrome.
    Eur Heart J. 2021 Sep 1. pii: 6361017. doi: 10.1093.
    >> Share

  349. ELLIOTT AD, Middeldorp ME, Linz DK
    The ins and outs of physical activity monitoring: implications for atrial fibrillation management.
    Eur Heart J. 2021 Sep 1. pii: 6361015. doi: 10.1093.
    >> Share

    August 2021
  350. BRIGNOLE M, Pentimalli F, Palmisano P, Landolina M, et al
    AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.
    Eur Heart J. 2021 Aug 28. pii: 6358077. doi: 10.1093.
    >> Share

  351. CURTAIN JP, Docherty KF, Jhund PS, Petrie MC, et al
    Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
    Eur Heart J. 2021 Aug 27. pii: 6358075. doi: 10.1093.
    >> Share

  352. WILLEMS S, Borof K, Brandes A, Breithardt G, et al
    Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
    Eur Heart J. 2021 Aug 27. pii: 6358078. doi: 10.1093.
    >> Share

  353. LIGHT PE
    Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure.
    Eur Heart J. 2021 Aug 27. pii: 6358226. doi: 10.1093.
    >> Share

  354. CHIANG PH, Hsu YC, Wei JC
    Methodological considerations when discussing the fracture risk of atrial fibrillation patients taking different drug.
    Eur Heart J. 2021 Aug 11. pii: 6348063. doi: 10.1093.
    >> Share

  355. HUANG HK, Tu YK, Loh CH
    Fracture risk associated with different oral anticoagulants in patients with atrial fibrillation: updated evidence from real-world observational studies and clinical trials.
    Eur Heart J. 2021 Aug 11. pii: 6348060. doi: 10.1093.
    >> Share

  356. WANG N, Sun Y, Zhang H, Wang B, et al
    Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease.
    Eur Heart J. 2021 Aug 10. pii: 6347324. doi: 10.1093.
    >> Share

  357. SALEM JE, Nguyen LS, Moslehi JJ, Ederhy S, et al
    Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study.
    Eur Heart J. 2021 Aug 9. pii: 6346756. doi: 10.1093.
    >> Share

  358. NICHOLLS M
    Reflections on EHRA 2021.
    Eur Heart J. 2021;42:2880-2881.
    >> Share

  359. RASMUSSEN PV, Hylek E
    Persistence with treatment in atrial fibrillation: still a pressing issue in the era of direct oral anticoagulants.
    Eur Heart J. 2021 Aug 4. pii: 6339772. doi: 10.1093.
    >> Share

  360. ROMITI GF, Corica B, Pipitone E, Vitolo M, et al
    Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
    Eur Heart J. 2021 Aug 1. pii: 6333297. doi: 10.1093.
    >> Share

  361. REIFFEL JA
    When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease.
    Eur Heart J. 2021 Aug 1. pii: 6333293. doi: 10.1093.
    >> Share

    July 2021
  362. WILDE AAM, Wu CI
    Does function trump bioinformatics in Brugada syndrome-associated SCN5A mutation calling? Patients, computers, and patches.
    Eur Heart J. 2021;42:2864-2865.
    >> Share

  363. ISHIKAWA T, Kimoto H, Mishima H, Yamagata K, et al
    Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
    Eur Heart J. 2021;42:2854-2863.
    >> Share

  364. ALHUMAID W, Yogasundaram H, Senaratne JM
    Slow bidirectional ventricular tachycardia as a manifestation of immune checkpoint inhibitor myocarditis.
    Eur Heart J. 2021;42:2868.
    >> Share

  365. GUASCH E, Nattel S
    Ageing, comorbidities, and the complex determinants of atrial fibrillation in athletes.
    Eur Heart J. 2021 Jul 23. pii: 6327053. doi: 10.1093.
    >> Share

  366. ADABAG S, Madjid M, Cheng A
    An attempt to reconcile the contrasting results of analyses on implantable cardioverter-defibrillator shocks during the pandemic.
    Eur Heart J. 2021 Jul 19. pii: 6323687. doi: 10.1093.
    >> Share


  367. Erratum to: Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 - a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke.
    Eur Heart J. 2021 Jul 16. pii: 6322394. doi: 10.1093.
    >> Share

  368. TOOROP MMA, Chen Q, Tichelaar VYIG, Cannegieter SC, et al
    Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
    Eur Heart J. 2021 Jul 16. pii: 6322389. doi: 10.1093.
    >> Share

  369. BUNTING KV, Stanbury M, Tica O, Kotecha D, et al
    Transforming clinical research by involving and empowering patients- the RATE-AF randomized trial.
    Eur Heart J. 2021;42:2411-2414.
    >> Share

    June 2021

  370. Erratum to: Alcohol Consumption, Cardiac Biomarkers and Risk of Atrial Fibrillation and Adverse Outcomes.
    Eur Heart J. 2021 Jun 30. pii: 6311430. doi: 10.1093.
    >> Share

  371. VAN DER REE MH, Postema PG
    What's in a name? further classification of patients with apparent idiopathic ventricular fibrillation.
    Eur Heart J. 2021 Jun 21. pii: 6306957. doi: 10.1093.
    >> Share

  372. SCHNABEL RB, Fabritz L, Kirchhof P
    Mobile health for walking on the tightrope of optimal physical activity to reduce the risk of atrial fibrillation.
    Eur Heart J. 2021 Jun 20. pii: 6306826. doi: 10.1093.
    >> Share


  373. Corrigendum to: A huge atrial thrombus in a patient with bioprosthetic valve and atrial fibrillation: something went wrong with anticoagulation therapy.
    Eur Heart J. 2021 Jun 16. pii: 6300115. doi: 10.1093.
    >> Share

  374. VERSTRAELEN TE, van Lint FHM, Bosman LP, de Brouwer R, et al
    Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.
    Eur Heart J. 2021 Jun 11. pii: 6296140. doi: 10.1093.
    >> Share

  375. LEE SR, Choi EK, Jung JH, Han KD, et al
    Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study.
    Eur Heart J. 2021 Jun 7. pii: 6294435. doi: 10.1093.
    >> Share

    May 2021
  376. KHURSHID S, Weng LC, Al-Alusi MA, Halford JL, et al
    Accelerometer-derived physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 May 25. pii: 6283622. doi: 10.1093.
    >> Share

  377. PARK S, Lee S, Kim Y, Lee Y, et al
    Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study.
    Eur Heart J. 2021 May 23. pii: 6282432. doi: 10.1093.
    >> Share

  378. BENN M
    Atrial Fibrillation And Chronic Kidney Disease.
    Eur Heart J. 2021 May 23. pii: 6282434. doi: 10.1093.
    >> Share

  379. TOMSITS P, Clauss S, Kaab S
    Genetic insight into sick sinus syndrome. Is there a pill for it or how far are we on the translational road to personalized medicine?
    Eur Heart J. 2021;42:1972-1975.
    >> Share

  380. MARSTON NA, Han L, Olivotto I, Day SM, et al
    Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:1988-1996.
    >> Share

  381. THOROLFSDOTTIR RB, Sveinbjornsson G, Aegisdottir HM, Benonisdottir S, et al
    Genetic insight into sick sinus syndrome.
    Eur Heart J. 2021;42:1959-1971.
    >> Share

  382. THOROLFSDOTTIR RB, Sveinbjornsson G, Aegisdottir HM, Benonisdottir S, et al
    Genetic insight into sick sinus syndrome.
    Eur Heart J. 2021;42:1959-1971.
    >> Share

  383. STEINBERG C, Davies B, Mellor G, Tadros R, et al
    Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry.
    Eur Heart J. 2021 May 19. pii: 6278425. doi: 10.1093.
    >> Share

  384. CSENGERI D, Sprunker NA, Schnabel RB
    Alcohol and atrial fibrillation: dose matters, not so much the type.
    Eur Heart J. 2021 May 9. pii: 6272848. doi: 10.1093.
    >> Share

  385. MESSERLI FH, Dobner S
    Alcohol and atrial fibrillation: not all drinks are created equal.
    Eur Heart J. 2021 May 8. pii: 6272093. doi: 10.1093.
    >> Share

  386. KROHN-GRIMBERGHE M, Duerschmied D, Bode C
    What do we learn by repeating the ABC?
    Eur Heart J. 2021;42:1707-1709.
    >> Share

  387. GNECCHI M, Sala L, Schwartz PJ
    Precision Medicine and cardiac channelopathies: when dreams meet reality.
    Eur Heart J. 2021;42:1661-1675.
    >> Share

  388. DELISE P
    Risk stratification in Brugada syndrome: the challenge of the grey zone.
    Eur Heart J. 2021;42:1696-1697.
    >> Share

  389. PROBST V, Goronflot T, Anys S, Tixier R, et al
    Robustness and relevance of predictive score in sudden cardiac death for patients with Brugada syndrome.
    Eur Heart J. 2021;42:1687-1695.
    >> Share

  390. MINOIS D, Sellal JM, Magnin I, de Chillou C, et al
    Left ventricular diverticulum associated with two concealed atrioventricular accessory pathways.
    Eur Heart J. 2021;42:1714.
    >> Share

    April 2021
  391. GALIUTO L, Volpe M
    Cryoblation as first-line treatment of new-onset atrial fibrillation?
    Eur Heart J. 2021;42:1543-1544.
    >> Share

  392. SMOLDEREN KG, Burg MM
    A broken heart after child loss.
    Eur Heart J. 2021;42:1496-1498.
    >> Share

  393. BRIEGER D, Freedman B
    Decoding stroke risk scores in atrial fibrillation: still more work to do.
    Eur Heart J. 2021 Apr 6. pii: 6213361. doi: 10.1093/eurheartj/ehaa1111.
    >> Share

    March 2021
  394. EL-BATTRAWY I, Lang S, Zhou X, Akin I, et al
    Different genotypes of Brugada syndrome may present different clinical phenotypes: electrophysiology from bench to bedside.
    Eur Heart J. 2021;42:1270-1272.
    >> Share

  395. PAPPONE C, Ciconte G, Micaglio E, Monasky MM, et al
    Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value.
    Eur Heart J. 2021;42:1273-1274.
    >> Share

  396. YOUNIS A, Goldenberg I
    Extending the MADIT-ICD benefit score to heterogenous heart failure populations.
    Eur Heart J. 2021 Mar 18. pii: 6177051. doi: 10.1093.
    >> Share

  397. POSTEMA PG, Walsh R, Bezzina CR
    Illuminating the path from genetics to clinical outcome in Brugada syndrome.
    Eur Heart J. 2021;42:1091-1093.
    >> Share

  398. BEHR ER, Ben-Haim Y, Ackerman MJ, Krahn AD, et al
    Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway?
    Eur Heart J. 2021;42:1073-1081.
    >> Share

  399. CICONTE G, Monasky MM, Santinelli V, Micaglio E, et al
    Brugada syndrome genetics is associated with phenotype severity.
    Eur Heart J. 2021;42:1082-1090.
    >> Share

  400. IRIART X, Metras A, Coiffic A, Thambo JB, et al
    Late device-related thrombus after left atrial appendage closure: never let your guard down.
    Eur Heart J. 2021;42:1050.
    >> Share

    February 2021
  401. SAWANO S, Nakayama A, Morita H, Komuro I, et al
    Rathke's cleft cyst induced cardiac arrest.
    Eur Heart J. 2021;42:714.
    >> Share

  402. CRIJNS HJGM, Prinzen F, Lambiase PD, Sanders P, et al
    The year in cardiovascular medicine 2020: arrhythmias.
    Eur Heart J. 2021;42:499-507.
    >> Share

  403. SCHNEEWEIS C, Ahrens I, Saygili E, Steven D, et al
    Cardiac involvement in sarcoidosis and necessary ventricular tachycardia ablation.
    Eur Heart J. 2021;42:544.
    >> Share

    January 2021
  404. KITE TA, Gershlick AH
    High-risk NSTE-ACS: high time for robust data.
    Eur Heart J. 2021;42:352.
    >> Share

  405. HAMILTON GW, Lim HS
    Ventricular tachycardia vs. supraventricular tachycardia with aberrancy.
    Eur Heart J. 2021;42:133.
    >> Share

    December 2020
  406. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
    Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
    Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
    >> Share

  407. WILDE AAM, Lodder EM
    Biomarkers in inherited arrhythmias: necessity for validation and collaboration.
    Eur Heart J. 2020;41:4523-4524.
    >> Share

  408. HAMILTON RM, Chatterjee D, Saguner AM
    Biomarkers in inherited arrhythmias: opportunities for validation and collaboration.
    Eur Heart J. 2020;41:4521-4522.
    >> Share

    November 2020
  409. VERHAMME P, Budts W, Van de Werf F
    Non-vitamin K oral anticoagulants in adults with congenital heart disease: quod non?
    Eur Heart J. 2020;41:4178-4180.
    >> Share

    April 2020
  410. HILDICK-SMITH D, Landmesser U, Camm AJ, Diener HC, et al
    Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study.
    Eur Heart J. 2020 Apr 3. pii: 5815608. doi: 10.1093.
    >> Share

    January 2020
  411. FAROUX L, Chen S, Muntane-Carol G, Regueiro A, et al
    Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.
    Eur Heart J. 2020 Jan 3. pii: 5695667. doi: 10.1093.
    >> Share

    December 2019
  412. LANCINI D, Shetty R
    Tension pneumothorax: a Brugada phenocopy and ST-elevation myocardial infarction mimic.
    Eur Heart J. 2019 Dec 28. pii: 5688935. doi: 10.1093.
    >> Share

  413. KALLA M, Hao G, Tapoulal N, Tomek J, et al
    The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
    Eur Heart J. 2019 Dec 13. pii: 5675548. doi: 10.1093.
    >> Share

    August 2019
  414. PACKER M
    What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?
    Eur Heart J. 2019 Aug 7. pii: 5544750. doi: 10.1093.
    >> Share

    June 2019
  415. REDDY YNV, Borlaug BA, O'Connor CM, Gersh BJ, et al
    Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions.
    Eur Heart J. 2019 Jun 14. pii: 5519089. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016